About Melinta

Melinta Therapeutics is a biopharmaceutical company founded by Sterling Professors at Yale University

Our mission is to apply Nobel Prize–winning science to develop new therapeutics in the global fight against drug-resistant pathogens.

We are the proud developers of BAXDELA™, an important therapeutic milestone in the treatment of serious skin infections in adult patients.

Melinta Therapeutics

Our Pipeline

Melinta Program pipeline chart